+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Sepsis Diagnostics: Global Markets

  • PDF Icon

    Report

  • 114 Pages
  • April 2022
  • Region: Global
  • BCC Research
  • ID: 5578869
The current report provides detailed exposure to the sepsis diagnostic market. This report highlights the current and future market potential of sepsis diagnostics, as well as a detailed analysis of market drivers, challenges and opportunities. The report also covers market projections to 2026 and market shares for key market players. It details the market share of sepsis diagnostics based on technology type, product, diagnostic method and pathogen type. The report includes company profiles of the key players, with detailed information regarding their business segments, financials, product portfolios and recent developments. The report also provides the impact of the COVID-19 pandemic on this market. The regional market has been segmented into North America, Europe, Asia-Pacific and the Rest of the world. For market estimates, data have been provided for 2019 as the historic year and 2020 as the base year, with a forecast for 2026.



Report Includes

  • 35 data tables and 15 additional tables
  • An updated overview of the global sepsis diagnostics market
  • Analyses of the global market trends, with data from 2019 to 2021, and projections of compound annual growth rates (CAGRs) through 2026
  • Evaluation and forecast the global market size for sepsis diagnostics, and corresponding market share analysis by product, technology type, diagnostic method, test type, pathogen, end user and geographic region
  • Highlights the current and future market potential of sepsis diagnostics along with a detailed analysis of the drivers, challenges, and opportunities in the market
  • Identification of promising new products and technologies still in the development and assess the probability that they will be commercialized successfully in the next five years
  • Discussion of the COVID-19 implications on the market for sepsis clinical diagnostics and research studies
  • Information pertaining to the companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
  • Insight into the recent industry structure, current competitive scenario, R&D activities, product launch strategies and company value share analysis based on their segmental revenues
  • Descriptive company profiles of the leading global players, including Abbott Laboratories, Bruker Corp., Roche Diagnostics Corp., Siemens Healthineers AG and Thermo Fisher Scientific Inc

Table of Contents

Chapter 1 Introduction
  • Study Goals and Objectives
  • Reasons for Doing this Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • Custom Research
  • Related Research Reports

Chapter 2 Summary and Highlights
Chapter 3 Technology Background
  • Introduction
  • Causes
  • Risk Factors
  • Symptoms
  • Pathophysiology
  • Endothelial Dysfunction
  • Coagulopathy
  • Cardiovascular Dysfunction
  • Cellular Dysfunction
  • Epidemiology and Economic Burden
  • Diagnosis and Treatment
  • Regulatory Scenario
  • Regulations in North America
  • European Regulations

Chapter 4 Market Dynamics
  • Factors Affecting the Sepsis Diagnostic Market
  • Market Drivers
  • Increasing Incidence of Infectious Diseases
  • Rising Aging Population and Increasing Incidence of Chronic Diseases
  • Increasing Government Initiatives
  • Technological Developments
  • Market Restraints
  • High Cost of Instruments and Lack of Skilled Workforce
  • Opportunities
  • Demand for Rapid and Accurate Diagnostic Tool

Chapter 5 Impact of Covid-19
  • Introduction
  • Outbreak
  • Covid-19 Symptoms
  • Covid-19 Progression
  • Incubation Period
  • Epidemiology
  • Collaboration Between Organizations and Governments
  • Spread of Disease
  • Impact of Covid-19 on the Sepsis Diagnostic Market

Chapter 6 Sepsis Diagnostic Market by Technology
  • Global Sepsis Diagnostic Market by Technology
  • Microbiological Tests
  • Immunoassays
  • Molecular Diagnostics
  • Others

Chapter 7 Sepsis Diagnostic Market by Product
  • Assays and Reagents
  • Culture Media
  • Instruments
  • Software

Chapter 8 Sepsis Diagnostic Market by Method
  • Conventional Diagnostics
  • Automated Diagnostics

Chapter 9 Sepsis Diagnostic Market by Test Type
  • Laboratory Tests
  • Point-Of-Care Tests

Chapter 10 Sepsis Diagnostic Market by Pathogen Type
  • Bacterial Sepsis
  • Fungal Sepsis
  • Others

Chapter 11 Sepsis Diagnostic Market by End-user
  • Hospitals and Clinics
  • Diagnostic Centers
  • Academic and Research Institutions

Chapter 12 Sepsis Diagnostic Market by Region
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Chapter 13 Competitive Landscape and Analysis of Market Opportunities
  • Recent Developments
  • Mergers, Acquisitions and Collaborations
  • Sepsis Diagnostic Company Market Shares

Chapter 14 Company Profiles
  • Abbott Laboratories
  • Axis-Shield Diagnostics Ltd.
  • Becton, Dickinson & Company
  • Biomerieux
  • Bruker Corp.
  • Danaher
  • Ekf Diagnostics Holdings plc
  • Immunexpress
  • Luminex Corp.
  • Qiagen Nv
  • Roche Diagnostics Corp.
  • Seegene
  • Siemens Healthineers AG
  • T2 Biosystems
  • Thermo Fisher Scientific Inc.

Companies Mentioned

  • Abbott Laboratories
  • Axis-Shield Diagnostics Ltd.
  • Becton, Dickinson & Company
  • Biomerieux
  • Bruker Corp.
  • Danaher
  • Ekf Diagnostics Holdings plc
  • Immunexpress
  • Luminex Corp.
  • Qiagen Nv
  • Roche Diagnostics Corp.
  • Seegene
  • Siemens Healthineers AG
  • T2 Biosystems
  • Thermo Fisher Scientific Inc.

Table Information